High-Purity Citric Acid Market Size and Share

High-Purity Citric Acid Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

High-Purity Citric Acid Market Analysis by Mordor Intelligence

The high-purity citric acid market size is expected to increase from USD 0.55 billion in 2025 to USD 0.61 billion in 2026 and reach USD 0.82 billion by 2031, growing at a CAGR of 7.2% over 2026-2031. The high-purity citric acid market is expanding faster than the broader citric acid space because buyers in pharmaceuticals and specialty food manufacturing are shifting toward certified grades with tighter purity control and multi-compendial compliance requirements. The high-purity citric acid market also benefits from the wider use of citric acid as a chelating agent, pH buffer, and formulation aid in oral drugs, effervescent products, and biologics processing. Food reformulation is adding another layer of demand as sugar reduction programs and clean label positioning require more consistent acidulation and batch performance in premium products. The high-purity citric acid market is therefore moving away from a simple commodity model and toward a certification-driven supply model that favors producers with strong purification systems, analytical control, and reliable documentation. The high-purity citric acid market also leaves room for suppliers that can offer diversified regional production and application-specific grades as customers try to reduce quality and supply risk

Key Report Takeaways

  • By purity grade, Pharma Grade held 51.38% of the market in 2025, while Food Grade is forecast to expand at an 8.68% CAGR through 2031.
  • By form, Powder or Crystalline held 67.21% of the high-purity citric acid market share in 2025, while Liquid recorded the highest projected CAGR at 8.35% through 2031.
  • By application, Pharmaceuticals accounted for 38.28% of the high-purity citric acid market size in 2025, while Food and Beverages are advancing at an 8.55% CAGR through 2031.
  • By geography, Asia-Pacific led with a 42.64% revenue share in 2025, while Europe is forecast to grow at an 8.15% CAGR through 2031.

Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.

Segment Analysis

By Purity Grade: Pharmaceutical Dominance Tested by Food-Grade Momentum

Pharma Grade held 51.38% of the market in 2025, which made it the largest purity segment in the high-purity citric acid market. This position reflects the fact that regulated drug products require material aligned with USP, EP, JP, or similar standards, which keeps demand relatively captive. The high-purity citric acid market continues to rely on pharmaceutical use as an anchor because excipient performance and compliance are both essential in oral and parenteral formulations. Suppliers with multi-compendial certification hold an advantage because they reduce qualification complexity for global buyers.

Food Grade is projected to grow at an 8.68% CAGR from 2026 to 2031, which makes it the fastest-growing purity segment in the high-purity citric acid market. This rise does not weaken the pharmaceutical premium because much of the momentum comes from applications such as infant formula, clinical nutrition, and nutraceutical products, where specification standards are also strict. The high-purity citric acid industry is therefore seeing more overlap between advanced food applications and pharma-linked quality expectations. Industrial Grade remains smaller within this report's scope because its end uses are less sensitive to the purity and documentation requirements that define premium demand. The segment mix shows that volume growth is broadening, while value capture still depends heavily on certification depth.

High-Purity Citric Acid Market: Market Share by Purity Grade
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

By Form: Crystalline Still Leads, but Liquid Gains Strategic Ground

Powder or Crystalline held 67.21% of the high-purity citric acid market share in 2025, which kept it as the dominant form segment. This leadership comes from long-established use in dry blend foods, solid dosage pharmaceuticals, and effervescent systems where storage stability and handling are central. Anhydrous crystalline material remains especially important in moisture-sensitive applications because it supports stable processing and predictable reaction behavior in tablet production. The high-purity citric acid market still leans on this format because it fits existing manufacturing lines and multiple granulation requirements.

Liquid is projected to expand at an 8.35% CAGR through 2031, making it the fastest-growing form segment in the high-purity citric acid market. Demand is rising in syrups, oral solutions, and pediatric formulations where precise pH control and homogeneous dispersion matter more than dry handling convenience. Biologics processing also supports this shift because liquid citrate buffer systems help maintain consistent concentration and stability during downstream use. The high-purity citric acid market is therefore seeing liquid gain strategic importance even while crystalline material remains the volume base. This change reflects a broader move toward application specific supply rather than one form serving every use case.

By Application: Pharma Anchors Value, Food and Beverages Drives Volume Growth

Pharmaceuticals accounted for 38.28% of the high-purity citric acid market size in 2025, which kept it as the largest application in the high-purity citric acid market. The segment benefits from several concurrent functions, including pH adjustment, buffering, chelation, effervescence, and support for bioavailability enhancement. These roles make certified citric acid difficult to replace because product quality and regulatory acceptance depend on consistent input specifications. The high-purity citric acid market also sees this application retain pricing resilience because buyers cannot simply move down the grade ladder when compliance is involved.

Food and beverages are forecast to grow at an 8.55% CAGR to 2031, making it the fastest-growing application in the high-purity citric acid market. Clean label reformulation, sugar reduction, functional beverages, and gummy supplements are widening the number of products that need steady tartness and pH performance. Producers of pectin-based gummies and premium beverages need more batch consistency than standard acidulation uses, which strengthens demand for higher specification material. Cosmetics and Personal Care, Analytical and Laboratory Use, and Others remain relevant complementary outlets in the high purity citric acid market. The application mix shows that pharmaceuticals still anchor value, while food linked innovation is widening the growth base.

High-Purity Citric Acid Market: Market Share by Application
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
High-Purity Citric Acid Market: Market Share by Application

Geography Analysis

Asia-Pacific held 42.64% of the market in 2025, giving it the leading position in the high-purity citric acid market. The region combines large-scale fermentation capacity with strong downstream demand from pharmaceuticals and food processing. China remains central because its production system benefits from feedstock access, fermentation scale, and integrated manufacturing structures that support cost efficiency. India strengthens the regional demand picture through its large pharmaceutical formulation base and continuing need for certified excipients in regulated products. The high-purity citric acid market in Asia-Pacific therefore reflects both production strength and expanding local consumption.

Europe is projected to grow at an 8.15% CAGR from 2026 to 2031, making it the fastest-growing regional segment in the high-purity citric acid market. Demand is being supported by pharmaceutical, nutraceutical, premium food, and personal care buyers who value tightly documented supply and certified grades. The region also places a higher premium on dependable sourcing after recent years of freight and supply disruption. The high-purity citric acid market in Europe is therefore growing on quality assurance and sourcing strategy rather than on low cost production.

North America remains an important part of the high purity citric acid market because it has major domestic ingredient producers and a large base of pharmaceutical and food customers. Strategic investment is reshaping the region, as Jungbunzlauer closed its Illinois facility acquisition in 2025 to establish a U.S. manufacturing footprint for premium ingredients. South America and the Middle East and Africa are smaller in current scale, but they continue to add demand through food processing expansion and regional pharmaceutical trade flows. The high purity citric acid market across these regions remains less mature, yet their incremental demand supports a broader global customer base.

High-Purity Citric Acid Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The high-purity citric acid market shows medium concentration and a clear two-tier structure. One group consists of large integrated producers with fermentation scale, purification capability, and broad pharmacopeial certification coverage. Another group serves selected applications or regions with narrower product portfolios and less extensive documentation depth. The high-purity citric acid market rewards suppliers that can combine quality assurance, multi-region delivery, and application-specific technical support. Certification breadth remains a basic requirement for access to many higher-value accounts.

A visible strategy in the high-purity citric acid market is geographic diversification of production. Jungbunzlauer strengthened that approach when it closed the acquisition of the Thomson, Illinois, site in November 2025 and established its first U.S. manufacturing base. The same company also advanced expansion at Port Colborne in 2026 as part of a broader investment program tied to fermentation-based ingredients. These steps show that the high-purity citric acid market is placing more value on regional manufacturing resilience and shorter customer lead times.

Another strategic pattern in the high purity citric acid market is process improvement and research led differentiation. Jungbunzlauer’s collaboration with TU Wien focused on refining Aspergillus niger strains to improve citric acid production efficiency and sustainability linked metrics. RZBC also remained relevant in regulated trade flows after U.S. authorities maintained a zero antidumping rate in the 2023 to 2024 review period, reinforcing its compliance position in the U.S. market[3]Source: U.S. Department of Commerce, “Citric Acid and Certain Citrate Salts From the People's Republic of China: Final Results of Antidumping Duty Administrative Review, 2023-2024,” Federal Register, govinfo.gov. The high purity citric acid market is therefore competing not only on output volume, but also on documentation strength, process control, and the ability to serve tightly regulated end uses. Suppliers that align grade purity with specific applications are likely to hold the strongest position.

High-Purity Citric Acid Industry Leaders

  1. Jungbunzlauer Suisse AG

  2. Cargill, Incorporated

  3. COFCO Biotechnology Co., Ltd.

  4. Archer Daniels Midland Company

  5. Citribel NV

  6. *Disclaimer: Major Players sorted in no particular order
High-Purity Citric Acid Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • April 2026: Brenntag Pharma introduced BYPHAR, a specialized biopharma manufacturing brand designed to provide high-quality raw materials, regulatory support, and value-added services across the entire biopharmaceutical production lifecycle.Through partnerships with leading ingredient suppliers such as Budenheim, Citribel, K+S, and Kerry, the platform offers high-purity phosphates, citric acid and citrates, pharmaceutical-grade salts, and acetates for applications.
  • January 2025: Brenntag Pharma has extended its partnership with Citribel for the distribution of citric acids and citrate pharma excipients, expanding beyond France, Spain, Germany, and Benelux to now include Israel, Turkey, and South Africa.
  • November 2024: Jungbunzlauer announced a collaboration with the Technical University of Vienna (TU Wien) to support research at the newly established Christian Doppler Laboratory focused on optimizing citric acid production through advanced fungal strain development. The research aims to improve citric acid yields by identifying and enriching naturally efficient fungal strains using molecular analysis, genetic screening, and innovative mRNA measurement techniques.

Table of Contents for High-Purity Citric Acid Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Use in Pharmaceutical Excipients and Oral Drug Formulations
    • 4.2.2 Rising Use in Biotechnology Fermentation Media and Cell Culture Applications
    • 4.2.3 Increasing Use in Premium Confectionery and Sugar-Free Candies
    • 4.2.4 Growing Use in Effervescent Tablets and Powders
    • 4.2.5 Increasing Demand from Infant Formula and Clinical Nutrition Products
    • 4.2.6 Nutraceutical Gummies and Dietary Supplements Facing Stronger Demand
  • 4.3 Market Restraints
    • 4.3.1 High Production and Purification Costs
    • 4.3.2 Supply Chain Disruptions for Feedstocks
    • 4.3.3 Competition from Alternative Acidulants
    • 4.3.4 Stringent Regulatory Compliance Requirements
  • 4.4 Supply Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces
    • 4.7.1 Bargaining Power of Suppliers
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Threat of New Entrants
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Purity Grade
    • 5.1.1 Pharma Grade
    • 5.1.2 Food Grade
    • 5.1.3 Industrial Grade
  • 5.2 By Form
    • 5.2.1 Powder/Crystalline
    • 5.2.2 Liquid
  • 5.3 By Application
    • 5.3.1 Food and Beverages
    • 5.3.2 Pharmaceuticals
    • 5.3.3 Cosmetics and Personal Care
    • 5.3.4 Analytical and Laboratory Use
    • 5.3.5 Others
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.1.4 Rest of North America
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Netherlands
    • 5.4.2.7 Sweden
    • 5.4.2.8 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
    • 5.4.5.1 United Arab Emirates
    • 5.4.5.2 South Africa
    • 5.4.5.3 Rest of Middle East and Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Ranking Analysis
  • 6.4 Company Profiles (Includes Global-level Overview, Market-level Overview, Core Segments, Financials, Strategic Info, Market Rank/Share, Products & Services, Recent Developments)
    • 6.4.1 Jungbunzlauer Suisse AG
    • 6.4.2 Cargill, Incorporated
    • 6.4.3 Archer Daniels Midland Company
    • 6.4.4 COFCO Biotechnology Co., Ltd.
    • 6.4.5 TTCA CO., LTD.
    • 6.4.6 Shandong Ensign Industry Co., Ltd.
    • 6.4.7 Citribel NV
    • 6.4.8 Gadot Biochemical Industries Ltd.
    • 6.4.9 RZBC Group Co., Ltd.
    • 6.4.10 Huangshi Xinghua Biochemical Co., Ltd.
    • 6.4.11 Foodchem International Corporation
    • 6.4.12 Merck KGaA
    • 6.4.13 Brenntag SE
    • 6.4.14 Roquette Frères
    • 6.4.15 Tate and Lyle PLC
    • 6.4.16 Corbion N.V.
    • 6.4.17 Xitrical Co., Ltd.
    • 6.4.18 ECSA Chemicals AG
    • 6.4.19 Hubei Xingfa Chemicals Group Co., Ltd.
    • 6.4.20 Jiangsu Guoxin Union Energy Co., Ltd.

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Global High-Purity Citric Acid Market Report Scope

By Purity Grade
Pharma Grade
Food Grade
Industrial Grade
By Form
Powder/Crystalline
Liquid
By Application
Food and Beverages
Pharmaceuticals
Cosmetics and Personal Care
Analytical and Laboratory Use
Others
By Geography
North AmericaUnited States
Canada
Mexico
Rest of North America
EuropeGermany
United Kingdom
France
Italy
Spain
Netherlands
Sweden
Rest of Europe
Asia-PacificChina
India
Japan
Australia
South Korea
Rest of Asia-Pacific
South AmericaBrazil
Argentina
Rest of South America
Middle East and AfricaUnited Arab Emirates
South Africa
Rest of Middle East and Africa
By Purity GradePharma Grade
Food Grade
Industrial Grade
By FormPowder/Crystalline
Liquid
By ApplicationFood and Beverages
Pharmaceuticals
Cosmetics and Personal Care
Analytical and Laboratory Use
Others
By GeographyNorth AmericaUnited States
Canada
Mexico
Rest of North America
EuropeGermany
United Kingdom
France
Italy
Spain
Netherlands
Sweden
Rest of Europe
Asia-PacificChina
India
Japan
Australia
South Korea
Rest of Asia-Pacific
South AmericaBrazil
Argentina
Rest of South America
Middle East and AfricaUnited Arab Emirates
South Africa
Rest of Middle East and Africa

Key Questions Answered in the Report

What is the 2031 outlook for high purity citric acid?

The market is forecast to reach USD 0.82 billion by 2031 from USD 0.61 billion in 2026, at a 7.21% CAGR over 2026 to 2031.

Which purity segment leads demand for high specification citric acid?

Pharma Grade led in 2025 with 51.38% share because regulated drug products require tightly certified input materials.

Which form is growing fastest in citric acid for regulated applications?

Liquid is projected to grow the fastest at an 8.35% CAGR through 2031, supported by oral liquid drugs and biologics buffer use.

Which region offers the strongest growth opportunity through 2031?

Europe is expected to post the fastest regional growth at 8.15% CAGR, supported by demand for dependable certified supply.

Page last updated on: